Our Issels® immunotherapy for cancer programs are integrative, combining different approaches that focus on the body’s natural defense mechanisms. Good nutrition is essential to keeping your immune system running at maximum strength to target and attack cancer cells.
Eating Right to Fight Cancer
Nutritional immunotherapy for cancer focuses on creating a diet that allows the body to break down and utilize food with maximum efficiency. It goes beyond finding the proper balance of protein, carbohydrates and fats to include choosing foods in their natural state that are rich in vitamins, minerals and antioxidants.
Consuming foods in the right combination is another important element of nutritional immunotherapy. The correct balance of acids and alkalines improves cell and tissue health while preventing undue strain on digestive organs.
How Poor Nutrition Affects Health
Research has discovered links between the development of cancer and poor nutritional habits such as excessive consumption of red meat and high-fat foods. Metabolic stress has also been found to diminish the effectiveness of the immune system and deplete muscle strength.
Our immunotherapy treatments are individually tailored to meet each patient’s unique needs. Nutritional programs are designed to correct nutritional deficiencies, support optimum functioning of the immune system and other organs, and boost the level of nutrients that increase NK cell activity.
Immunotherapy Offers Hope for Cancer Patients
Other non-toxic immunotherapy for cancer programs at Issels® include vaccines, stem cell treatments and systemic hyperthermia. Visit our website to read and hear testimonials from patients who have been successfully treated for leukemia, carcinoma, melanoma and many other forms of cancer.
After years of research, scientists are still unable to pinpoint the causes and predictors of cancer with absolute certainty. The good news is that immunotherapy for cancer now offers hope for patients who previously had few options.
An Immunotherapy Success Story
One such patient was Tish Vigna. Four years ago she was diagnosed with stage 3 cancer in her left lung, despite being a physically fit non-smoker. She underwent a course of chemotherapy, radiation and surgery only to discover that the cancer had spread to her right lung.
Tish’s oncologist suggested that she enter a clinical trial of immunotherapy for cancer at Princess Margaret Hospital in Toronto. After months of treatment, doctors found that the tumors had shrunk in half and there has been no subsequent growth.
How Does Immunotherapy Work?
Immunotherapy is a process of boosting the ability of your own immune system to fight cancer cells naturally. These treatments generally fall within two categories:
With adoptive T-cell therapy, doctors extract the attacking T-cells from a patient’s tumor to increase their numbers. The cells are then re-entered into the patient’s system where they are now better equipped for battle.
The immune system has a braking mechanism that prevents it from going into overdrive. Checkpoint inhibitors disable these brakes so the T-cells can attack cancer cells with full force.
Issels®: Leading the Way with Immunotherapy
While immunotherapy for cancer has been making a big splash in the medical community recently, Issels® has been successfully using these personally tailored treatments for decades. Contact us today for more information about our immunotherapy programs such as cancer vaccines and NK cells.
Vaccines have played a landmark role in medical history, helping to control or eradicate major diseases such as smallpox, measles, flu and polio. This effective form of treatment is also a significant part of our Issels® integrative immunotherapy for cancer programs.
How Do Vaccines Work?
The science behind vaccines may sound counterintuitive. Many vaccines are made from a weakened form of the microorganism that it’s being developed to fight. Once introduced into your system, the vaccines “teach” your immune system to recognize the microorganism as a threat to be attacked and destroyed.
The Issels® Vaccine Program
Our personalized cancer vaccines and cell therapy protocols are created from the patient’s own immune cells and combined with the immunobologic core treatment to target the tumor and its specific microenvironment to optimize their results.
We offer specialized cancer vaccines at the Issels® immuno-oncology center, including Autologous Dendritic Cells Cancer Vaccine, Prostate Cancer Vaccine, as well as the Issels Autologous Vaccine and combine them with the Lymphokine-Activated Killer (LAK) Cell and Natural Killer (NK) Cell protocols.
These vaccines and cell therapies are autologous, meaning they are created from the patient’s own blood. Since the blood cells provide information about the patient’s internal environment, the vaccines can be tailored to target the patient’s unique cancer-fighting properties.
Immunotherapy for Cancer: Boosting Your Body’s Natural Defenses
Cancer vaccines are only one of the non-toxic protocols we use to activate your body’s own immune response against tumors. Contact us today to learn why Issels® has been a leader in immunotherapy for cancer treatments for more than 50 years.
Immunotherapy is the general term for treating disease by affecting the immune system. Suppression immunotherapy restrains the immune system as opposed to cancer immunotherapy, which focuses on activating the immune response.
The immune system is the network that keeps your body safe from viruses, bacteria and other disease-causing organisms. When a foreign substance enters your system, it triggers an immune response to eliminate the threat.
Many types of cancer cells have the ability to slide “under the radar” and avoid detection by immune cells, giving them the opportunity to multiply and travel to other parts of the body. Immunotherapy works to remove the “shield” around cancer cells and help the immune system do its job.
Why Has Immunotherapy Become So Important?
Cancer immunotherapy treatments are created to specifically target cancer cells, so they have been useful against increasingly diverse forms of cancer.
Immunotherapy has fewer side effects than traditional treatments such as chemotherapy and radiation.
Many immunotherapy treatments have proved to be successful, encouraging continued research and development.
Issels®: An Integrative Approach to Cancer Treatment
For more than 50 years, Issels® has been a leader in the development and use of innovative immunotherapy programs. No two cases of cancer are the same, and we use comprehensive testing to formulate personalized treatments. Visit our website for more information about our non-toxic therapies.
One of the highlights of immunotherapy for cancer is that the protocols are personally tailored to address your individual needs. A research team at the University of Michigan recently developed a way to customize cancer vaccines that holds promise for both current treatment and long-term immunity.
“Training” the Immune System
Immunotherapy for cancer focuses on helping your own immune system battle cancer cells. The vaccine created by the University of Michigan team uses synthetic high-density lipoproteins called nanodiscs to train the immune system to recognize and attack cancer cells.
Nanodiscs use patient-specific genetic mutations, or tumor neoantigens, to trigger production of T-cells by the immune system. The T-cells then use the genetic material in the nanodiscs to target the cancer cells.
The study involved treating mice suffering from melanoma and colon cancer with a combination of checkpoint inhibitors and the nanodisc vaccine. Not only were most of the tumors eliminated, the mice remained tumor-free after the same cancer cells were reintroduced into their systems after 70 days.
University of Michigan Goes All-In on Nanodisc Research
Encouraged by the results of the test, the University of Michigan has created a biotech company named EVOQ Therapeutics to concentrate on developing and refining the nanodisc vaccine. Plans are to conduct further studies on animals before moving into clinical trials.
Issels®: Blazing the Immunotherapy for Cancer Trail
Cancer vaccines are just one of the innovative non-toxic treatments we employ at Issels®. Visit our website to learn more about our specialized testing methods and individualized integrative programs.
Researchers continue to make strides in discovering new cancer immunotherapy methods that help doctors successfully target tumor cells. As revealed in a recently published report, a team of scientists at the Medical University of South Carolina (MUSC) have created a promising antibody-based therapy using a specific diagnostic marker known as GARP.
When Immune Cells Fail
Numerous studies have focused on TGF-beta, which is a protein used by regulatory T-cells (Tregs) to direct immune cells away from healthy cells. Malignant tumors get around this by releasing vast amounts of TGF-beta, essentially hijacking Tregs and causing them to suppress immune cell activity against the cancer cells.
GARP is the only known receptor that lets TGF-beta dock on cell surfaces. The MUSC team set out to determine whether GARP was the means by which tumor cells were able to harness TGF-beta.
Is GARP the Key to Activating Tregs?
After finding that GARP levels were higher in certain types of tumors, the team conducted a test in which they removed the GARP gene from mice with mammary tumors. As a result, the tumors grew more slowly and there was little metastasis to the lungs.
The MUSC team then used human GARP in mice to develop antibodies. Their hope is that in the future, cancer immunotherapy in conjunction with GARP antibodies will result in more effective treatment for breast cancer.